In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression
The post-hoc analysis sought to identify factors predictive of relapse and disability progression in people with MS enrolled in the TRANSFORMS study.
CMSC 2017
Ocrelizumab May Improve Cognitive Function in Relapsing Multiple Sclerosis
Researchers sought to determine whether treatment with ocrelizumab improved measures of cognitive function better than interferon beta 1-a.
Teriflunomide for MS Associated With Low Rates of Infection, Lymphopenia
Initial trials of teriflunomide have demonstrated low lymphocyte counts in patients with relapsing forms of MS.
In Multiple Sclerosis, Hand Strength May Indicate Disease Status
In patients with MS, hand function often correlates with measures of quality of life.
Multiple Sclerosis May Have Causal Link to Osteoporosis
The prevalence of osteoporosis was greater in patients with MS than in matched controls.
In MS, Anxiety, Cognitive Fatigue May Affect Visual Memory
Cognitive fatigue and anxiety are common symptoms reported by patients with multiple sclerosis.
Multiple Sclerosis Relapse Rate Linked to Puberty in Boys
Boys with onset of MS during puberty experienced an increased rate of relapse compared with boys with MS onset before or after puberty.
Want to read more?
Please login or register first to view this content.
Next post in CMSC 2017
